QGA
ASND icon

Q Global Advisors’s Ascendis Pharma A/S ASND Stock Holding History

Q Global Advisors’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.7M Hold
100,000
– – 17.01% 1
2026
Q1 		$22.9M Sell
100,000
-90,000
-47% -$20.2M 20.17% 1
2025
Q4 		$40.5M Buy
190,000
+20,000
+12% +$4.13M 39.86% 1
2025
Q3 		$33.8M Sell
170,000
-85,000
-33% -$15.9M 53.09% 1
2025
Q2 		$44M Buy
255,000
+6,113
+2% +$996K 37.03% 1
2025
Q1 		$38.8M Buy
248,887
+29,428
+13% +$4.2M 31.55% 2
2024
Q4 		$30.2M Hold
219,459
– – 31.14% 1
2024
Q3 		$32.8M Hold
219,459
– – 28.82% 1
2024
Q2 		$29.9M Sell
219,459
-65,541
-23% -$8.92M 21.23% 1
2024
Q1 		$43.1M Hold
285,000
– – 16.34% 3
2023
Q4 		$35.9M Hold
285,000
– – 27.2% 1
2023
Q3 		$26.7M Buy
285,000
+90,000
+46% +$8.42M 17.16% 2
2023
Q2 		$17.4M Buy
195,000
+96,429
+98% +$8.39M 12.55% 4
2023
Q1 		$10.6M Sell
98,571
-52,838
-35% -$6.04M 7.4% 4
2022
Q4 		$18.5M Buy
151,409
+6,200
+4% +$720K 8.95% 5
2022
Q3 		$16.7M Buy
145,209
+25,209
+21% +$2.39M 11.49% 3
2022
Q2 		$11.2M Sell
120,000
-40,500
-25% -$3.82M 8.65% 4
2022
Q1 		$18.8M Buy
160,500
+44,615
+38% +$5.17M 11.54% 4
2021
Q4 		$15.6M Buy
115,885
+49,171
+74% +$7.31M 3.58% 7
2021
Q3 		$10.6M Buy
66,714
+16,993
+34% +$2.33M 8.85% 4
2021
Q2 		$6.54M Buy
49,721
+22,657
+84% +$3.02M 4.57% 6
2021
Q1 		$3.49M Buy
27,064
+3,881
+17% +$590K 0.89% 25
2020
Q4 		$3.87M Buy
+23,183
New +$3.83M 2.72% 13

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Q Global Advisors's ASND Position: Q2 2026 in Review

Q Global Advisors held its Ascendis Pharma A/S (ASND) position steady in Q2 2026 at 100,000 shares worth $26.7M. The position accounts for 17.01% of the portfolio, ranked #1.

Q Global Advisors first reported a position in ASND in Q4 2020 and has held it in 23 quarters since. The position peaked at $44M in Q2 2025. 311 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

  • Q Global Advisors held 100,000 shares of Ascendis Pharma A/S worth $26.7M as of Q2 2026.
  • Q Global Advisors left its Ascendis Pharma A/S share count unchanged in Q2 2026.
  • Ascendis Pharma A/S made up 17.01% of Q Global Advisors's portfolio in Q2 2026, its #1 holding.
  • Q Global Advisors first reported a position in Ascendis Pharma A/S in Q4 2020 and has held it in 23 quarters since.
  • Q Global Advisors's Ascendis Pharma A/S position peaked at $44M in Q2 2025.
  • 311 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Q Global Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.